Moderna in final talks to build an mRNA manufacturing and R&D hub in the UK — report

Moderna is reportedly getting ready to take a big step directly into the European arena.

The big biotech, propelled by tens of billions of dollars in sales for its Covid-19 mRNA vaccine, is putting the finishing touches to an agreement with the UK government to build out new R&D and manufacturing facilities in the Golden Triangle — ground zero for the country’s biopharma and scientific complex.